PubMed · 2000 · 44 citations · 29 references
Open access
MedicineOncologyPathologyChemotherapyMolecular OncologyRenal PathologyKidney CancerMalignant NeoplasmsPediatric TumorsRenal NeoplasmsTumor Suppressor GenesWilms TumorCell Growth RegulationImmunohistochemical BiomarkersImmunohistochemical DetectionImmunohistochemical MarkersImmunohistochemical StainingPediatric Renal NeoplasmsPrognostic Marker EvaluationWilms Tumor 1
Wilms' tumor is one of the most common solid tumors of children. The protein product of the tumor-suppressor gene, Wilms' tumor 1 (WT-1), binds to the same DNA sequences as the protein product of the early growth response 1 (EGR-1) gene. There is experimental evidence that EGR-1 is involved in controlling cell growth. The expression of both genes in Wilms' tumor was studied by others, mainly at the mRNA level. The present study evaluates the prognostic value of WT-1 and EGR-1 in 61 Wilms' tumors of chemotherapeutically treated patients at the protein level, using an immunohistochemical approach. WT-1 was expressed in normal kidney tissues and in the blastemal and epithelial component of Wilms' tumor, whereas stromal tissue was negative. EGR-1 was expressed in normal kidney tissues and in the three main cell types of Wilms' tumor. In 59 and 56% of Wilms' tumor, the blastemal cells stained for WT-1 and EGR-1, respectively. The blastemal expression of WT-1 and EGR-1 and the epithelial expression of WT-1 were statistically significantly correlated with clinical stage. WT-1 immunoreactivity correlated with EGR-1 expression. Univariate analysis showed that blastemal WT-1 and EGR-1 expression were indicative for clinical progression and tumor-specific survival, whereas epithelial staining was of no prognostic value. Multivariate analysis showed that blastemal WT-1 expression is an independent prognostic marker for clinical progression other than stage. We conclude that a relationship exists between WT-1 and EGR-1 expression in clinical nephroblastomas. Blastemal WT-1 and EGR-1 expression is related to prognosis.
29
The candidate Wilms' tumour gene is involved in genitourinary development
Kathy Pritchard‐Jones, Stewart Fleming, Duncan Davidson et al. · Nature · 1990 · 879 citations
Kazushi Inoue, Haruo Sugiyama, Hiroyasu Ogawa et al. · Blood · 1994 · 575 citations · Full text
Medicine, Hematology, Oncology +16
Transcriptional Repression Mediated by the WT1 Wilms Tumor Gene Product
Donna Cook, Jennifer Morris, Andrea Gashler et al. · Science · 1991 · 487 citations